715 related articles for article (PubMed ID: 33346905)
21. Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S; Tripathi P
J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
[TBL] [Abstract][Full Text] [Related]
22. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
23. A review of metabolic potential of human gut microbiome in human nutrition.
Yadav M; Verma MK; Chauhan NS
Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
[TBL] [Abstract][Full Text] [Related]
24. [Microbiome, diabetes and heart: a novel link?].
Kappel BA; Lehrke M
Herz; 2019 May; 44(3):223-230. PubMed ID: 30847506
[TBL] [Abstract][Full Text] [Related]
25. Beneficial actions of microbiota-derived tryptophan metabolites.
Galligan JJ
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 29341448
[TBL] [Abstract][Full Text] [Related]
26. Microbiome response to diet: focus on obesity and related diseases.
Delzenne NM; Rodriguez J; Olivares M; Neyrinck AM
Rev Endocr Metab Disord; 2020 Sep; 21(3):369-380. PubMed ID: 32691288
[TBL] [Abstract][Full Text] [Related]
27. Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions.
Chen EB; Cason C; Gilbert JA; Ho KJ
J Gastrointest Surg; 2018 Jun; 22(6):1112-1123. PubMed ID: 29623674
[TBL] [Abstract][Full Text] [Related]
28. [The relationship between gut microbiota and cardiovascular diseases].
Gerardi V; Del Zompo F; D'Aversa F; Gasbarrini A
G Ital Cardiol (Rome); 2016 Jan; 17(1):11-4. PubMed ID: 26901254
[TBL] [Abstract][Full Text] [Related]
29. Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health.
Jardon KM; Canfora EE; Goossens GH; Blaak EE
Gut; 2022 Jun; 71(6):1214-1226. PubMed ID: 35135841
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiome, endocrine control of gut barrier function and metabolic diseases.
Régnier M; Van Hul M; Knauf C; Cani PD
J Endocrinol; 2021 Feb; 248(2):R67-R82. PubMed ID: 33295880
[TBL] [Abstract][Full Text] [Related]
31. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria.
Schwenger KJP; Bolzon CM; Li C; Allard JP
Eur J Nutr; 2019 Aug; 58(5):1771-1784. PubMed ID: 30306296
[TBL] [Abstract][Full Text] [Related]
32. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
Massey W; Brown JM
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
[TBL] [Abstract][Full Text] [Related]
33. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
[TBL] [Abstract][Full Text] [Related]
34. Gut mycobiome and metabolic diseases: The known, the unknown, and the future.
Wang L; Zhang K; Zeng Y; Luo Y; Peng J; Zhang J; Kuang T; Fan G
Pharmacol Res; 2023 Jul; 193():106807. PubMed ID: 37244385
[TBL] [Abstract][Full Text] [Related]
35. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
36. Sex, gut microbiome, and cardiovascular disease risk.
Razavi AC; Potts KS; Kelly TN; Bazzano LA
Biol Sex Differ; 2019 Jun; 10(1):29. PubMed ID: 31182162
[TBL] [Abstract][Full Text] [Related]
37. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.
Paun A; Danska JS
Pediatr Diabetes; 2016 Nov; 17(7):469-477. PubMed ID: 27484959
[TBL] [Abstract][Full Text] [Related]
38. Role of the gut microbiota in type 2 diabetes and related diseases.
Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
[TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.
He X; Ji G; Jia W; Li H
Int J Mol Sci; 2016 Mar; 17(3):300. PubMed ID: 26999104
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
